Women and Cardiovascular Disease: The Gender Gap

Dear Colleagues,

Cardiovascular disease (CVD) is the leading cause of death among women in the Western world. Although age-adjusted mortality in women has decreased globally in the past 30 years, CVD in women is remaining un(der)recognized, leading to a low percentage of inclusion in scientific trials, adequate diagnosis and treatment. Awareness has been raised over the last years to decrease sex and gender-related gaps in CVD. CVD accounts for a global disease burden among women, with an especially high prevalence in specific geographic regions and among certain ethnicities. Additionally, we want to emphasize the importance of conversional phases of female lives to prevent, diagnose and treat CVD among women as best as possible. Besides hormones, many factors contribute to this inequity in the detection and management of CVD. Gender-specific, as well as classic cardiovascular risk factors will be addressed. Furthermore, focus will be set on optimal medical treatment, interventional and surgical procedures for heart failure, female entities of coronary heart disease, valvular heart disease, aortic pathologies, arrhythmias and related basic science. Stress as a risk factor is much more relevant for females’ cardiovascular system. The topics may include the impact of sex and gender-related disparities in research.

Dr. Sandra Eifert
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• interventional and surgical treatment of women and cardiovascular disease
• heart failure
• coronary and valvular heart disease
• aortic pathologies
• arrhythmias and related basic science
• risk factors
• hormones